Zoetis Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bearish -25

Zoetis Cuts Outlook Following Challenging 1Q

AI-generated analysis

πŸ“‰ Zoetis shares fell 7.8% in premarket trading to $102.50 after the company cut its full-year outlook.

πŸ’Έ Over the past year, the stock has lost approximately one-third of its value through Wednesday's close.

πŸ“Š First-quarter earnings were $601 million, a slight decrease from $602 million in the prior year.

🧠 Adjusted first-quarter earnings of $1.53 per share missed Wall Street models that expected $1.60.

πŸ“ˆ Q1 revenue rose 2.9% to $2.26 billion but came in short of the $2.3 billion analyst consensus.

πŸ’¬ CEO Kristin Peck attributed the weak performance to increased pet owner price sensitivity and intense competition.

🐾 Peck noted a decline in veterinary visits and softer demand for premium innovative pet products.

⚑ Management plans to take decisive actions to sharpen execution, unlock revenue, and drive cost management.

🎯 Zoetis now expects full-year earnings between $6.35 and $6.50 per share on a GAAP basis.

πŸ’΅ On an adjusted basis, the company projects annual earnings of $6.85 to $7 per share.

πŸ“‰ This represents a downgrade from the previous guidance of $6.65 to $6.75 in GAAP earnings.

πŸ“ Previously, the company had guided for adjusted earnings between $7 and $7.10 per share.

πŸ’° The new full-year revenue forecast ranges from $9.68 billion to $9.96 billion.

πŸ‘‡ This is a revision down from the prior view of $9.83 billion to $10.03 billion for annual revenue.

⚠️ The outlook cuts reflect a challenging first quarter that exceeded expectations in both earnings and revenue misses.

Bullish Signals
  • Zoetis plans to take decisive actions moving forward to sharpen execution, unlock revenue, and drive cost management.
  • Despite the challenging quarter, revenue still climbed 2.9% year-over-year to $2.26 billion.
Risk Factors
  • Zoetis cut its full-year earnings guidance to $6.35-$6.50 per share, down from a previous expectation of $6.65-$6.75.
  • The company lowered revenue projections to between $9.68 billion and $9.96 billion, a decline from the prior view of $9.83 billion-$10.03 billion.
  • First-quarter earnings dropped slightly to $601 million compared to $602 million in the same quarter last year.
  • Adjusted quarterly earnings of $1.53 per share fell below Wall Street analyst models which projected $1.60 per share.
  • Revenue for the first quarter of $2.26 billion missed the $2.3 billion consensus estimate despite a year-over-year increase.
  • Shares experienced significant declines, falling 7.8% in premarket trading and losing about one-third of their value over the past year.
  • The animal health sector faces headwinds including increased price sensitivity among pet owners, reduced veterinary visits, and softer demand for premium products.
Full Analysis
Zoetis, the animal health company listed under ticker ZTS, issued a downward revision to its full-year financial guidance following a disappointing first quarter performance that fell below analyst expectations. The stock price dropped approximately 7.8% in premarket trading and has declined about one-third of its value over the past year. CEO Kristin Peck attributed the challenges primarily to increased price sensitivity among pet owners, which led to reduced veterinary visits and weaker demand for premium innovative products, alongside intensified competition in key pet care categories. In its updated outlook, Zoetis lowered its full-year earnings guidance to between $6.35 and $6.50 per share on a reported basis and $6.85 to $7.00 per share adjusted, down from previously expected ranges of $6.65 to $6.75 and $7.00 to $7.10 respectively. The company also reduced its revenue forecast to a range of $9.68 billion to $9.96 billion, decreasing from prior estimates of $9.83 billion to $10.03 billion. For the first quarter specifically, Zoetis reported net income of $601 million compared to $602 million in the year-ago period, with adjusted earnings of $1.53 per share missing the $1.60 consensus estimate. While quarterly revenue grew 2.9% year-over-year to $2.26 billion, it still came in below the $2.3 billion analysts had predicted. In response to the challenging quarter, Peck stated the company intends to take decisive actions to improve execution, unlock revenue, and drive cost management moving forward. The article notes that Zoetis has seen sustained pressure on sales as consumer spending habits shift toward more budget-conscious choices in the pet care sector.